The presence of abnormal mammalian target of rapamycin (mTOR) and related mTOR-mediated signaling has been demonstrated in several syndromic ASD models, including TSC, Fragile X syndrome, Rett syndrome, and Angelman syndrome (Winden et al., 2018). This evidence concerns the gene MTOR and atypical Rett syndrome.